Kiora Pharmaceuticals Operating Margin Growth & History (KPRX)
Kiora Pharmaceuticals's operating margin was 28.15% for fiscal 2024.
View full Kiora Pharmaceuticals company overviewKiora Pharmaceuticals annual operating margin history
2018
2020
2024
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 28.15% | — |
| 2020 | 2020-12-31 | −56,960.51% | — |
| 2018 | 2018-12-31 | −656.25% | — |
Kiora Pharmaceuticals quarterly operating margin
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q4.20
Q1.24
Q2.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | −12,724.44% | — |
| Q1 2024 | 2024-03-31 | 82.64% | — |
| Q4 2020 | 2020-12-31 | −9,698.80% | — |
| Q1 2019 | 2019-03-31 | 30.85% | +247.92 pp |
| Q3 2018 | 2018-09-30 | −1,010.45% | +4532.15 pp |
| Q2 2018 | 2018-06-30 | −1,156.27% | +1087.17 pp |
| Q1 2018 | 2018-03-31 | −217.06% | +1365.11 pp |
| Q3 2017 | 2017-09-30 | −5,542.60% | −4311.44 pp |
| Q2 2017 | 2017-06-30 | −2,243.44% | −612.54 pp |
| Q1 2017 | 2017-03-31 | −1,582.17% | — |
| Q3 2016 | 2016-09-30 | −1,231.17% | — |
| Q2 2016 | 2016-06-30 | −1,630.90% | — |
Kiora Pharmaceuticals operating margin trends
Between the periods ended 2018-12-31 and 2024-12-31, Kiora Pharmaceuticals's operating margin increased from −656.25% to 28.15%, a change of +684.41 percentage points. The latest reported quarter, Q2 2024, shows −12,724.44%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiora Pharmaceuticals source filings ↗